SYGNIS AG

euro adhoc: LION Bioscience AG
Annual & Special Corporate Meetings / LION bioscience AG Receives Non-binding and Non-specific Take-over Respectively Purchase Offer

---------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------

24.03.2005

In today’s extraordinary shareholder’s meeting the shareholder Ian Humphrey-Smith informed the audience and LION bioscience AG about a likely non-binding and non-specific take-over respectively purchase offer for LION bioscience AG respectively for its assets. Mr. Humphrey-Smith indicated that he would not act on his own behalf, but on behalf of a group of investors namely FM Fund Management Ltd. and Zapis Capital Group.

In case of a binding and specific take-over respectively purchase offer, LION bioscience AG would review such an offer seriously.

end of announcement                                euro adhoc 24.03.2005 14:01:16
---------------------------------------------------------------------

Further inquiry note: Günter Dielmann Vice President Investor Relations +49 (0) 6221-4038 249

Branche: Biotechnology
ISIN:      DE0005043509
WKN:        504350
Index:    Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Berliner Wertpapierbörse / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade
              Bremer Wertpapierbörse (BWB) / free trade



Weitere Meldungen: SYGNIS AG

Das könnte Sie auch interessieren: